We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Patient Dosing in Phase 2 Clinical Trial of Puricase for Severe Gout Completed
Gout Savient Pharmaceuticals, Inc (NASDAQ: SVNT), an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs today announced the completion of patient dosing in a Phase 2 clinical trial of Puricase(R), a poly(ethylene glycol) ("PEG") conjugate of recombinant porcine uricase (urate oxidase), for the treatment of severe, refractory gout. [click link for full article]
Custom Search
